StonvexLoading…
StonvexStonvexStonvexCore line items from AVT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-28 | Q4 2025 2025-12-27 | Q3 2025 2025-09-27 | Annual 2025 2025-06-28 |
|---|---|---|---|---|
Revenue | $19.34B | $12.22B | $5.90B | $22.20B |
Operating Income | $493.76M | $288.23M | $142.03M | $514.25M |
Net Income | $207.81M | $61.73M | $51.74M | $240.22M |
EPS (Diluted) | $2.49 | $1.36 | $0.61 | $2.75 |
Total Assets | $13.49B | $13.15B | $12.41B | $12.12B |
Total Liabilities | $8.54B | $8.22B | $7.57B | $7.11B |
Cash & Equivalents | $202.44M | $286.55M | $175.47M | $192.43M |
Free Cash Flow OCF − CapEx | $-47.00M | $23.72M | $-169.17M | $577.03M |
Shares Outstanding | 83.39M | 83.63M | 84.46M | 87.41M |